Standardized measurement of dielectric materials' intrinsic triboelectric charge density through the suppression of air breakdown.

Triboelectric charge density and energy density are two crucial factors to assess the output capability of dielectric materials in a triboelectric nanogenerator (TENG). However, they are commonly limited by the breakdown effect, structural parameters, and environmental factors, failing to reflect the intrinsic triboelectric behavior of these materials. Moreover, a standardized strategy for quantifying their maximum values is needed. Here, by circumventing these limitations, we propose a standardized strategy employing a contact-separation TENG for assessing a dielectric material's maximum triboelectric charge and energy densities based on both theoretical analyses and experimental results. We find that a material's vacuum triboelectric charge density can be far higher than previously reported values, reaching a record-high of 1250 µC m-2 between polyvinyl chloride and copper. More importantly, the obtained values for a dielectric material through this method represent its intrinsic properties and correlates with its work function. This study provides a fundamental methodology for quantifying the triboelectric capability of dielectric materials and further highlights TENG's promising applications for energy harvesting.

Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.

Importance: Steroid hormone receptors, including estrogen receptor (ER) and progesterone receptor (PR), are crucial biomarkers in breast cancer (BC). However, limited data are available regarding single hormone receptor-positive (ER-positive/PR-negative and ER-negative/PR-positive) subtypes, rendering treatment decision and survival forecast difficult in patients with these BC subtypes. Objective: To investigate the clinicopathological characteristics and BC-specific survival (BCSS) of patients with single hormone receptor-positive BC. Design, Setting, and Participants: In this cohort study, data on patients diagnosed with BC between 1990 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results database (N = 1 158 032). Patients lacking information on ER status, PR status, or BCSS were excluded (n = 334 633). Comparisons were performed between single hormone receptor-positive BC and double hormone receptor-positive/double hormone receptor-negative BC. The dates of analysis were September 1, 2018, to June 31, 2019. Main Outcomes and Measures: The BCSS of patients with single hormone receptor-positive BC. Results: This cohort study included 823 399 patients with BC (818 002 women and 5397 men). The median (range) age at diagnosis was 60 (8-108) years, and the median (range) follow-up duration was 71 (0-311) months. The percentages of ER-positive/PR-positive, ER-positive/PR-negative, ER-negative/PR-positive, and ER-negative/PR-negative cases were 67.2%, 12.2%, 1.6%, and 19.0%, respectively. Single hormone receptor-positive subtypes showed distinct clinical characteristics compared with double hormone receptor-positive/double hormone receptor-negative subtypes. Multivariable Cox proportional hazards regression analysis showed that patients with ER-positive/PR-negative (hazard ratio [HR], 1.36; 95% CI, 1.34-1.38) and ER-negative/PR-positive (HR, 1.61; 95% CI, 1.55-1.67) tumors had worse BCSS than patients with the ER-positive/PR-positive subtype. In contrast, patients with ER-positive/PR-negative (HR, 1.27; 95% CI, 1.24-1.29) and ER-negative/PR-positive (HR, 1.07; 95% CI, 1.03-1.11) tumors had better BCSS than patients with the ER-negative/PR-negative subtype. The BCSS was statistically significantly worse in patients with ER-negative/PR-positive tumors than in patients with ER-positive/PR-negative tumors (HR, 1.18; 95% CI, 1.14-1.23). Conclusions and Relevance: In this cohort study, statistically significant distinctions between survival rates of patients with single hormone receptor-positive BC vs double hormone receptor-positive/double hormone receptor-negative BC were observed. Different strategies may be required for patients with single hormone receptor-positive tumors to ensure optimal treatment and maximum benefits from therapies.

Ultrafast Zinc-Ion Diffusion Ability Observed in 6.0-Nanometer Spinel Nanodots.

Rechargeable aqueous Zn-ion batteries (ZIBs) have recently attracted much attention due to their low cost and superior safety. Unfortunately, their low capacity and poor cycle life still hinder their practical application. Here, we have developed a general synthesis strategy for ultrasmall spinel oxide nanodots (Mn3O4, CoMn2O4, MnCo2O4.5, Co3O4, and ZnMn2O4) with abundant oxygen vacancies and highly active surface. Among them, 6.0-nanometer-sized Mn3O4 nanodots deliver the best Zn-ion storage ability with a high reversible capacity of 386.7 mA h g-1 at 0.1 A g-1, excellent rate performance, and a long-term stability of 500 cycles at 0.5 A g-1. Taking advantage of the highly activated surficial atoms, shortened transfer pathway, and introduction of numerous oxygen vacancies, an ultrahigh Zn2+ diffusion coefficient of 2.4 × 10-10 cm2 s-1 has been detected during the discharge process. This value is more than 2 orders of magnitude higher than that of other spinel oxide nanostructures in previous reports and also the highest one in all of the as-reported ZIB cathode materials to date. Our finding offers promising opportunities for the development of ZIB cathode materials with high energy density, long-term cycling stability, excellent flexibility, and wearability.